Mr. Brooke is Managing Member, PMSV Holdings LLC, and Chairman of Healthy Earth Strategic Holdings, an investment firm focused on aquaculture. He is the retired co-Founder and Managing Partner of venBio, a life sciences investment firm. He has over 30 years experience in life science analysis, investing and management. He is Director of Incyte, Cheyne Capital International Ltd, and Manning & Napier Mutual Funds. Mr. Brooke was an advisor to MPM Capital and a Member of the Board of Directors of the MPM Bio Equities Fund. He was the Global Head of Health Care Research and Strategy for Morgan Stanley and headed up Strategy, Research, and Economics for the Pacific Basin including Japan. Mr. Brooke was also a Managing Director at Tiger Management responsible for health care investing. Through his role as Chairman and CEO of Ithaka, he structured the purchase of Alsius Corp and successfully sold its assets to Zoll Medical in 2008.
Richard Fuller is an Australian-born, U.S.-based engineer, entrepreneur, and environmentalist best known for his work in global pollution remediation. He is founder and president of the nonprofit Pure Earth (formerly known as Blacksmith Institute) dedicated to solving pollution problems in low- and middle-income countries, where human health is at risk. Pure Earth focuses on polluted places where toxics cause significant public health risk, initiating projects that solve these exposures thus ensuring healthier lives for local inhabitants.
Mr. Fuller initiated and now leads the Secretariat of the Global Alliance on Health and Pollution, a multi-stakeholder group focusing on pragmatic solutions to pollution and health in the poorer countries. Members include World Bank, Asian Development Bank, UNEP, UNIDO, UNDP, and governments of over 25 countries severely affected by pollution.
In 2010, he was profiled in Time magazine’s Power of One column about his efforts fighting pollution. In 2014, Bloomberg Businessweek chronicled the growth of Blacksmith Institute/Pure Earth and Fuller’s work on toxic pollution problems around the world, including a dangerous cleanup of a secret former Soviet arms site in the Ukraine.
In October 2017, he co-chaired the seminal Lancet Commission on Pollution and Health. Bringing a group of 50 top researchers together and working for over two years, that report outlined the enormous health and economic costs of pollution, while also showing the pathways and solutions that can help cure what is now the largest cause of death in the world. The report had a global reach of unprecedented proportions, reaching 2 billion across the globe with over 4,000 media articles.
Mr. Fuller is also the founder and absentee Chairman of Great Forest Inc., one of the leading sustainability consulting companies in the U.S. He is the author of The Brown Agenda, published in 2015. He lives and is headquartered in New York. He is married, with three children. He is on the board of the Executive Committee of the Global Alliance of Health and Pollution, and New Partners in Community Revitalization.
Francois Guillon is the Senior Vice President of Omni Planning. Previously, he was the Global Head of Planning at Tiffany & Co. and was responsible for all of the company’s worldwide sales forecasting, inventory planning, assortment planning, and pricing. Prior to joining Tiffany, Francois worked in corporate finance at Citigroup. Francois earned an MBA from Baruch College and a Master of Philosophy from Universite Paris-Sorbonne.
Howard Hu, M.D., M.P.H., Sc.D.
Dr. Hu, a physician-scientist-epidemiologist, has been a tenured Professor, Director, Department Chair, and Dean in positions at Harvard (1990-2006), the University of Michigan (2006-2012), and the University of Toronto (2012-2018). He is currently Professor and the Flora L. Thornton Chair of the Department of Population and Public Health Sciences in the Keck School of Medicine of the University of Southern California. In terms of research interests, Dr. Hu has led international teams investigating the environmental, nutritional, social, genetic and epigenetic determinants of adult chronic disease and impaired child development in population-based studies based in the U.S., Mexico, India, China, and elsewhere around the world. His team’s work has been continuously funded by the U.S. National Institutes of Health and has generated over 350 publications and won many awards. Most recently, he co-initiated and continues to lead the Global Burden of Disease-Pollution, Climate and Health Initiative; and is currently leading several COVID-19 cohort studies based in the Los Angeles area. He has also served on 4 fact-finding missions, on the Board of Directors, and remains on the Advisory Board for Physicians for Human Rights (Nobel Peace Prize, 1997).
Kathryn Huarte is a Senior Business Development Executive with over 20 years experience in internet, finance and government. She develops and executes strategies to launch and grow organizations. As the founder of Huarte Advisors, Ms. Huarte consults start-up stage Internet companies on financing and operations, revises business plans, professionalizes marketing materials, recommends fundraising sources; advises on partnerships, business development and operational growth plans. Her clients include ArtSpace Marketplace; Plan Elements; ReFashioner.com; Chairsh.com; ArtandCulture.com.Ms. Huarte contributed to legislation and to form coalitions to grow San Francisco Internet Industry. Her experience ranges from Ebay and the United States Senate to NASA and Wooden Toy Distributors LP. She worked collaboratively with Budget, Tax, Small Business and Technology Departments.
David Hunter MBBS, MPH, ScD, FAFPHM
David Hunter is the Richard Doll Professor of Epidemiology and Medicine, University of Oxford; Vincent L. Gregory Professor of Cancer Prevention, Emeritus, Harvard T. H. Chan School of Public Health; Professor of Medicine, Emeritus, Harvard Medical School; Associate Member, Broad Institute of Harvard and MIT. His principal research interests are the etiology of cancer, particularly breast, prostate, pancreas and skin cancers. Previously he served as Dean for Academic Affairs at the Harvard T. H. Chan School of Public Health, Director of the Harvard Center for Cancer Prevention, and he was a founding Director of the Harvard T.H. Chan School’s program in Molecular and Genetic Epidemiology. He received his MBBS from the University of Sydney Medical School before earning his MPH and ScD from the Harvard School of Public Health.
Troy Hysmith is currently a Senior Director of Strategy, Operations, and Administration for The Nature Conservancy. He has held finance, operations, and strategy leadership positions across various industries including consumer banking (Bank of America), insurance, annuities, and wealth management (Jackson National Life Insurance/Distributors), broadcast and streaming media (NPR), and management consulting (Deloitte). Troy obtained a Masters from Columbia University, and both a Masters and Bachelors from the Georgia Institute of Technology.
Tabassum Inamdar is a long-time analyst of the banking and financial sector in India and Asia, and a more recent researcher of the impact sector. In 2019, she set up Tameel (https://tameel.in/), a research initiative focused on impact strategy research. Over the last two years, she has published three reports deconstructing CSR in India.
In February 2020, she was appointed a member of Committee setup by Insurance Regulatory and Development Authority of India on Development of Concept Paper on Standalone Micro-Insurance Company. From October 2018 to March 2020, she served as an Independent Director on the board of Zipsure a new general insurance start-up. Since October 2016, she has been on the board of Equitas Small Finance Bank and since December 2019, she have been on the board of Franklin Templeton AMC India as an independent director.
Her passion for BFSI research spans more than 25 years, having honed her domain expertise at several leading research houses – at Goldman Sachs where she was Managing Director (co-head, India Research and co-head, Asian financials), UBS Securities as Director (BFSI Research), Kotak Securities (Sr Equity Analyst – BFSI) and at Jardine Fleming.
Gloria Janata, J.D.
Gloria “Glo” Janata is an award-winning public relations strategist, marketing communications expert and issues management specialist with more than 25 years of agency, corporate and non-profit experience, focusing on health, well-being and beauty. As president of TogoRun, she is responsible for global operations, business development and the financial management of the agency, and provides senior counsel across accounts.
Since joining TogoRun in November 2012, Glo has led the team to achieve several of the most prestigious industry awards, including TogoRun being named by PRWeek Global as 2014 International Agency of the Year and best in class for Corporate Social Responsibility, and shortlisted by PRWeek Global as 2015 International Agency of the Year.
Glo has played a pivotal role elevating corporate reputations and brands for world-leading pharmaceutical companies, including Pfizer, Allergan, Schering-Plough, Bayer and Amgen. Programs under her leadership have won more than 220 industry awards, including the 2018 Sabre Award for Best Global Campaign for her work with Pure Earth on the launch of The Lancet Commission on Pollution and Health, which reached over 2 billion people worldwide.
Glo is also a seasoned advocate and licensed attorney, admitted to practice in Washington, DC, Pennsylvania and the U.S. Court of Appeals for the Fifth Circuit. Her proudest accomplishments include serving as senior vice president for non-profit Children’s Health Fund (CHF), where she focused on driving support for policy changes to provide access to healthcare for homeless and indigent U.S. children. She currently serves on CHF’s Advisory Council.
Glo began her public relations career at APCO and Hill & Knowlton in Washington, D.C. She was also part of the original leadership team at Chandler Chicco Agency (CCA), serving 16 years in various roles including co-head of the New York office, digital lead and the first managing director of Biosector 2. Immediately prior to assuming the helm of TogoRun, Glo served as Cohn & Wolfe’s global head of health and well-being.
Karen Mathiasen is a Project Director with the Center for Global Development and an Adjunct Professor at the Global Policy Program, Paul H. Nitze School of Advanced International Studies, Johns Hopkins. Karen is a former senior civil servant who worked at the U.S. Treasury in the Office of International Affairs under Presidents Clinton, Bush and Obama. She ran several regional offices covering the Middle East and North Africa, South and Central Asia, and Central and Southeastern Europe. Karen also spent six years heading the Office of Multilateral Development Banks (MDBs) and served as Acting U.S. Executive Director at the World Bank. Karen’s most recent position was as Senior Program Officer with the Development Policy and Finance team at the Gates Foundation.
Conrad Meyer III
During his 25-year career on Wall Street, Mr. Meyer was a founding member of Lehman Brothers’ Mergers and Acquisitions Department and went on to run the global M&A new business development efforts of Morgan Stanley and Gleacher Partners. In retirement, he has been involved with a variety of not-for-profit institutions and is currently an active member of the board of the American Red Cross in Greater New York. Mr. Meyer holds an undergraduate degree from Trinity College and an M.B.A. from Harvard Business School.
Ms. Mutoh has an eighteen year career in finance, primarily focusing on East Asian markets. She was the Executive Director at Indus Capital Partners in New York City. Before joining Indus, she was the Director of Prime Brokerage Sales Origination at Bank of America Merrill Lynch and led Pan Asian Equities Sales at Goldman Sachs for fifteen years. She was the founding member and Head of Market Analysis for an internet based start-up company focusingon English education in Tokyo. She’s a Council Leader at the U.S.-Japan Council – a nonprofit educational organization that contributes to strengthening U.S.-Japan relations – and has volunteered in humanitarian and disaster relief efforts in Japan.Ms. Mutoh holds a BA in History and a Certificate in Markets and Management from Duke University.
Alicia Ogawa is the director of the Project on Japanese Corporate Governance and Stewardship at Columbia Business School’s Center on Japanese Economy and Business, and an assistant adjunct Professor at Columbia’s School of International and Public Affairs. Since 2008, she has been a consultant to one of the largest U.S.-based activist hedge funds. Until 2006, she was managing director at Lehman Brothers, where she was responsible for managing the firm’s global equity research product. Prior to joining Lehman Brothers, Professor Ogawa spent 15 years in Tokyo, where she was a top-rated bank analyst and director of research for Nikko Salomon Smith Barneys. She is currently a member of the board of directors of the Maureen and Mike Mansfield Foundation and a member of the President’s Circle of the All Stars Project, a development program for inner city young people. Ogawa has been inducted into the Academy of Women Achievers, and now is a non-executive director at Tokyo-based Misaki Capital funds as well as at the London-based Nippon Active Value Fund. She is a member of the International Corporate Governance Network. She graduated from Barnard College and earned a master’s degree in international affairs at SIPA.
Mr. Roux received an M.A. in geology from Queens College, City University of New York, and a B.S. in engineering science from C.W. Post College, Long Island University. A Certified Professional Geologist and Hydrogeologist, he has served on the editorial board of “Ground Water Monitoring and Remediation” and currently is on the Board of Registration of the American Institute of Hydrology, the Technical Advisory Board of Pure Earth and the Board of Directors of the New York League of Conservation Voters Education Fund.
Roux Associates, which Mr. Roux founded in 1981, currently has more than 250 professional employees in six offices across the country. The firm provides a broad range of consulting and project management services to solve complex environmental problems. Roux Associates was twice named as one of America’s 500 fastest-growing private companies by “Inc. Magazine,” and since 1996 has been listed as one of the top 200 environmental consulting firms by “Engineering News Record”.
Ethan Sawyer is a Senior Managing Director with Guggenheim Securities, LLC’s Technology, Media and Telecommunications Investment Banking practice. Prior to joining Guggenheim, Ethan was a Managing Director at Morgan Stanley where he led the Global Entertainment Investment Banking practice. Prior to Morgan Stanley, Ethan worked as a consultant for Mercer Management Consulting in New York City. Ethan holds a J.D. from Harvard Law School and an A.B. from Dartmouth College.
Raised on a dairy farm in the English countryside, Ms. Triefus got her first significant taste of life in a developing country when she spent a year after high school in New Delhi, India managing quality control for an American fashion company. She came to America and received her bachelors degree from the University of Maryland, where she ran the Public Interest Resource Group’s Bottle Bill initiative. She subsequently earned her Masters degree in Media Ecology from New York University. After earning her masters, Ms. Triefus was the Program Coordinator at Tender Planet Marketing, developing environmental educational opportunities for corporations such as ACE Hardware and Thompson Vitamin, and then became Associate Account Manager at Markham Novell Communications where she created events for various luxury brands including Krug Champagne and Remy Martin. She later started her own company representing English fashion designers, and then inaugurated the Hands-On volunteering program at UJA Federation of New York. Ms. Triefus joined the Pure Earth board in 2012.